{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T16:41:26Z","timestamp":1788626486383,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.intimp.2025.114408","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T08:52:48Z","timestamp":1741855968000},"page":"114408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Dietary succinate supplementation alleviates DSS-induced colitis via the IL-4R\u03b1\/Hif-1\u03b1 Axis"],"prefix":"10.1016","volume":"152","author":[{"given":"Laiying","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buyun","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongdong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guijing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayasi","family":"Guleng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Chin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.intimp.2025.114408_bb0005","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41575-023-00854-4","article-title":"Deciphering the different phases of preclinical inflammatory bowel disease","volume":"21","author":"Rudbaek","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114408_bb0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1053\/j.gastro.2024.05.036","article-title":"Targeting the interleukin 23 pathway in inflammatory bowel disease","volume":"168","author":"Bourgonje","year":"2025","journal-title":"Gastroenterology"},{"issue":"10114","key":"10.1016\/j.intimp.2025.114408_bb0015","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.intimp.2025.114408_bb0020","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","article-title":"The four epidemiological stages in the global evolution of inflammatory bowel disease","volume":"18","author":"Kaplan","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.intimp.2025.114408_bb0025","first-page":"1143","article-title":"Representation and reporting of diverse groups in randomised controlled trials of pharmacological agents in inflammatory bowel disease: a systematic review, lancet","volume":"8","author":"Pathiyil","year":"2023","journal-title":"Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.intimp.2025.114408_bb0030","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3748\/wjg.v25.i9.1142","article-title":"Conventional therapy for moderate to severe inflammatory bowel disease: a systematic literature review","volume":"25","author":"Dami\u00e3o","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.intimp.2025.114408_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2023.07.001","article-title":"Recent advances in the treatment of IBD: targets, mechanisms and related therapies","volume":"71-72","author":"Liu","year":"2023","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.intimp.2025.114408_bb0040","doi-asserted-by":"crossref","first-page":"55","DOI":"10.14309\/ajg.0000000000002485","article-title":"A review of available medical therapies to treat moderate-to-severe inflammatory bowel disease","volume":"119","author":"Chang","year":"2024","journal-title":"Am. J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.intimp.2025.114408_bb0045","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s41573-024-00953-0","article-title":"Navigating the complexities of drug development for inflammatory bowel disease","volume":"23","author":"Honap","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.intimp.2025.114408_bb0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11894-020-00781-3","article-title":"Hepatotoxicty of agents used in the Management of Inflammatory Bowel Disease: a 2020 update","volume":"22","author":"Barnhill","year":"2020","journal-title":"Curr. Gastroenterol. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2025.114408_bb0055","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41467-019-13668-3","article-title":"Mitochondrial TCA cycle metabolites control physiology and disease","volume":"11","author":"Mart\u00ednez-Reyes","year":"2020","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.intimp.2025.114408_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2023.09.010","article-title":"Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn's Disease (EXPLORER)","volume":"22","author":"Colombel","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.intimp.2025.114408_bb0065","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2020.08.039","article-title":"pH-gated succinate secretion regulates muscle remodeling in response to exercise","volume":"183","author":"Reddy","year":"2020","journal-title":"Cell"},{"issue":"22","key":"10.1016\/j.intimp.2025.114408_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/nu16223828","article-title":"Succinic acid improves the metabolism of high-fat diet-induced mice and promotes White adipose Browning","volume":"16","author":"Yang","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.intimp.2025.114408_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106865","article-title":"Succinate signaling attenuates high-fat diet-induced metabolic disturbance and intestinal barrier dysfunction","volume":"194","author":"Li","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"41","key":"10.1016\/j.intimp.2025.114408_bb0080","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2404841121","article-title":"TCA metabolism regulates DNA hypermethylation in LPS and mycobacterium tuberculosis-induced immune tolerance","volume":"121","author":"Abhimanyu","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7444","key":"10.1016\/j.intimp.2025.114408_bb0085","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nature11986","article-title":"Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1","volume":"496","author":"Tannahill","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2025.114408_bb0090","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.celrep.2018.12.028","article-title":"Parabacteroides distasonis alleviates obesity and metabolic dysfunctions via production of succinate and secondary bile acids","volume":"26","author":"Wang","year":"2019","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.intimp.2025.114408_bb0095","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1007\/s10753-024-02021-6","article-title":"Succinic acid ameliorates Concanavalin A-induced hepatitis by altering the inflammatory microenvironment and expression of BCL-2 family proteins","volume":"47","author":"Cai","year":"2024","journal-title":"Inflammation"},{"issue":"1","key":"10.1016\/j.intimp.2025.114408_bb0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/0271678X211042112","article-title":"Focally administered succinate improves cerebral metabolism in traumatic brain injury patients with mitochondrial dysfunction","volume":"42","author":"Khellaf","year":"2022","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"1","key":"10.1016\/j.intimp.2025.114408_bb0105","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41385-018-0087-3","article-title":"Succinate receptor mediates intestinal inflammation and fibrosis","volume":"12","author":"Macias-Ceja","year":"2019","journal-title":"Mucosal Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2025.114408_bb0110","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1053\/j.gastro.2020.08.029","article-title":"Succinate produced by intestinal microbes promotes specification of tuft cells to suppress Ileal inflammation","volume":"159","author":"Banerjee","year":"2020","journal-title":"Gastroenterology"},{"issue":"23","key":"10.1016\/j.intimp.2025.114408_bb0115","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2216908120","article-title":"Tuft cells mediate commensal remodeling of the small intestinal antimicrobial landscape","volume":"120","author":"Fung","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.intimp.2025.114408_bb0120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.immuni.2018.06.016","article-title":"Detection of succinate by intestinal tuft cells triggers a type 2 innate immune circuit","volume":"49","author":"Nadjsombati","year":"2018","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.intimp.2025.114408_bb0125","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00441-023-03781-7","article-title":"Activating transcription factor 5 (ATF5) controls intestinal tuft and goblet cell expansion upon succinate-induced type 2 immune responses in mice","volume":"393","author":"Nakano","year":"2023","journal-title":"Cell Tissue Res."},{"issue":"2","key":"10.1016\/j.intimp.2025.114408_bb0130","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2018.05.014","article-title":"A metabolite-triggered tuft cell-ILC2 circuit drives small intestinal remodeling","volume":"174","author":"Schneider","year":"2018","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.intimp.2025.114408_bb0135","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/s41551-023-01050-0","article-title":"Resolving sepsis-induced immunoparalysis via trained immunity by targeting interleukin-4 to myeloid cells","volume":"7","author":"Schrijver","year":"2023","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.intimp.2025.114408_bb0140","series-title":"Macrophage Innate Training Induced by IL-4 and IL-13 Activation Enhances OXPHOS Driven Anti-Mycobacterial Responses, eLife 11","author":"Lundahl","year":"2022"},{"issue":"7","key":"10.1016\/j.intimp.2025.114408_bb0145","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/nprot.2017.044","article-title":"Chemically induced mouse models of acute and chronic intestinal inflammation","volume":"12","author":"Wirtz","year":"2017","journal-title":"Nat. Protoc."},{"issue":"5","key":"10.1016\/j.intimp.2025.114408_bb0150","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/ibd\/izad312","article-title":"Unveiling colitis: a journey through the dextran sodium sulfate-induced model","volume":"30","author":"Yang","year":"2024","journal-title":"Inflamm. Bowel Dis."},{"issue":"5","key":"10.1016\/j.intimp.2025.114408_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112471","article-title":"The glycolysis\/HIF-1alpha axis defines the inflammatory role of IL-4-primed macrophages","volume":"42","author":"Dang","year":"2023","journal-title":"Cell Rep."},{"issue":"11","key":"10.1016\/j.intimp.2025.114408_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/cells13110916","article-title":"Ly6C(hi) monocytes are metabolically reprogrammed in the blood during inflammatory stimulation and require intact OxPhos for chemotaxis and monocyte to macrophage differentiation","volume":"13","author":"Purvis","year":"2024","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.intimp.2025.114408_bb0165","doi-asserted-by":"crossref","first-page":"22451","DOI":"10.1038\/s41598-023-50059-7","article-title":"Depletion of muscularis macrophages ameliorates inflammation-driven dysmotility in murine colitis model","volume":"13","author":"Ferenczi","year":"2023","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.intimp.2025.114408_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107634","article-title":"\u03b2-Glucan induces protective trained immunity against mycobacterium tuberculosis infection: a key role for IL-1","volume":"31","author":"Moorlag","year":"2020","journal-title":"Cell Rep."},{"issue":"7585","key":"10.1016\/j.intimp.2025.114408_bb0175","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature16161","article-title":"Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit","volume":"529","author":"von Moltke","year":"2016","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.intimp.2025.114408_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/metabo10090372","article-title":"Succinate is an inflammation-induced Immunoregulatory metabolite in macrophages","volume":"10","author":"Harber","year":"2020","journal-title":"Metabolites"},{"issue":"7","key":"10.1016\/j.intimp.2025.114408_bb0185","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1007\/s00125-017-4261-z","article-title":"SUCNR1-mediated chemotaxis of macrophages aggravates obesity-induced inflammation and diabetes","volume":"60","author":"van Diepen","year":"2017","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.intimp.2025.114408_bb0190","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.immuni.2020.02.005","article-title":"Tuft-cell-derived leukotrienes drive rapid anti-helminth immunity in the small intestine but are dispensable for anti-protist immunity","volume":"52","author":"McGinty","year":"2020","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.intimp.2025.114408_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/biom9090486","article-title":"Succinate modulates intestinal barrier function and inflammation response in pigs","volume":"9","author":"Li","year":"2019","journal-title":"Biomolecules"},{"issue":"21","key":"10.1016\/j.intimp.2025.114408_bb0200","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1073\/pnas.1720758115","article-title":"Activation of intestinal tuft cell-expressed Sucnr1 triggers type 2 immunity in the mouse small intestine","volume":"115","author":"Lei","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.intimp.2025.114408_bb0205","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.immuni.2023.03.014","article-title":"The ins and outs of innate and adaptive type 2 immunity","volume":"56","author":"Molofsky","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2025.114408_bb0210","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.intimp.2019.02.028","article-title":"Dendritic cells treated by Trichinella spiralis muscle larval excretory\/secretory products alleviate TNBS-induced colitis in mice","volume":"70","author":"Jin","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.114408_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2021.108189","article-title":"Potential of human helminth therapy for resolution of inflammatory bowel disease: the future ahead","volume":"232","author":"Arai","year":"2022","journal-title":"Exp. Parasitol."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2025.114408_bb0220","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cell.2017.11.034","article-title":"Modulation of Myelopoiesis progenitors is an integral component of trained immunity","volume":"172","author":"Mitroulis","year":"2018","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.intimp.2025.114408_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e29686","article-title":"Monocytes and macrophages: origin, homing, differentiation, and functionality during inflammation","volume":"10","author":"Dash","year":"2024","journal-title":"Heliyon"},{"issue":"10401","key":"10.1016\/j.intimp.2025.114408_bb0230","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","article-title":"Ulcerative colitis","volume":"402","author":"Le Berre","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.intimp.2025.114408_bb0235","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/jama.2020.18936","article-title":"Management of Crohn Disease: a review","volume":"325","author":"Cushing","year":"2021","journal-title":"Jama"},{"issue":"5","key":"10.1016\/j.intimp.2025.114408_bb0240","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1053\/j.gastro.2022.01.023","article-title":"What does disease progression look like in ulcerative colitis, and how might it be prevented?","volume":"162","author":"Krugliak Cleveland","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2025.114408_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2021.108908","article-title":"Dietary succinate supplementation to maternal mice improves fetal brown adipose tissue development and thermogenesis of female offspring","volume":"100","author":"Liu","year":"2022","journal-title":"J. Nutr. Biochem."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925003984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925003984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T05:12:06Z","timestamp":1757913126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925003984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":49,"alternative-id":["S1567576925003984"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114408","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dietary succinate supplementation alleviates DSS-induced colitis via the IL-4R\u03b1\/Hif-1\u03b1 Axis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114408","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114408"}}